Table 8.
Recurrence rates in studies with non-seminomatous GCT patients in cSI managed with surveillance before 1992 and after 1993 [20, 21, 35]
![Recurrence rates in studies with non-seminomatous GCT patients in cSI managed with surveillance before 1992 and after 1993 [20, 21, 35]](https://karger.silverchair-cdn.com/karger/content_public/journal/uin/105/3-4/10.1159_000510407/2/000510407_t08.png?Expires=1757239976&Signature=JFMc4ClEL7SdvP6uXNNydklkgpOEFB6LMzLVdBitbQfP3wDeiJPgrd0QyLNzyFKi324jCYKlRpuyK0komzUX~NKRJLxieFggz5E~wmkbrouTygBEcdweFVRDKiPR1xF33On~C6m5pKyIdzalGuz29obB8umPr0282lqHwRMDfqjhLs8fAxKGU9JrAssC7aRsHjTeQcSXbqCo~4CAQc2v~ppis58Nd4e2MDSnm6l0PMFa0cQBd7PnKNU2lNopAwkRM~Si~R~9MZwAmlVbjVq79xEdoTirX2qh5wpzmhCeImposqVSwajIa3yrtum-waeeRYHZoY0kSyHnULQ7xNT3gw__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Recurrence rates in studies with non-seminomatous GCT patients in cSI managed with surveillance before 1992 and after 1993 [20, 21, 35]
